Paid Clinical Trials in Athens, GA
As of August 2026, 54 paid clinical trials are recruiting in Athens, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Athens offers studies at sites including University of Georgia for conditions such as Non-Small Cell Lung Cancer, Dyslipidemia, Non-small Cell Lung Cancer, Nutrition, Healthy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Athens
Trials by drug in Athens
Filter results
Newly added in Athens
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
51 clinical trials
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Mom Multi Postnatal Supplementation Trial
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
CLOZAPINE Response in Biotype-1
Harnessing Communication Preferences
Intermittent Cottonseed Oil Consumption
Steps Towards Osteoarthritis Prevention
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Post-Concussion Musculoskeletal Injury Risks
Cottonseed Oil Versus Matched PUFA Effects
Top Research Study Locations in Athens
Researchers run research studies in Athens, GA at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Georgia | Dyslipidemia, Nutrition, Healthy, Overweight and Obesity | 12 |
| University Cancer & Blood Center, LLC | Cachexia, Carcinoma, Carcinoma, Non-Small-Cell Lung | 7 |
| University Cancer and Blood Center LLC | Prostate Cancer, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 7 |
| University Cancer & Blood Center | Head and Neck Squamous Cell Carcinoma, Hodgkin Lymphoma, Malignant Melanoma | 4 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| University Cancer & Blood Center (UCBC) - Athens | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer | 2 |
| University Cancer and Blood Center | Locally Advanced Solid Tumors, Metastatic Solid Tumors, NSCLC | 2 |
| Center for Family Research | Substance Use | 1 |
| GA Interventional Pain-L, LLC | Lumbar Spinal Stenosis | 1 |
| Infectious Disease Consultants of Georgia | Clostridium Difficile Infection Recurrence | 1 |
| Local Institution - 0170 | Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC) | 1 |
| Physical Activity Measurement Lab | Compliance, Physical Activity, Sedentary Behaviors | 1 |
| Piedmont Heart of Athens | Atrial Fibrillation (AF) | 1 |
| Ramsey Student Center | Brain Injuries, Traumatic, Brain Injury Traumatic Mild, Concussion, Brain | 1 |
| Ramsey Student Center, University of Georgia | Healthy | 1 |
| Summit Clinical Research, LLC | C. Diff Infection, C.Difficile Diarrhea, CDI | 1 |
| UGA Bio-imaging Research Center | Message Exposure (Sequence: Flavor Then Regular), Message Exposure (Sequence: Regular Then Flavor), No Message Exposure (Control Condition) | 1 |
| UGA Clinical & Translational Unit | Postnatal Care | 1 |
| University Blood & Cancer Center, LLC | Breast Cancer | 1 |
| University Cancer & Blood Cent | Non-Small Cell Lung Cancer | 1 |
| University Cancer & Blood Center, LLC. | Triple Negative Breast Cancer | 1 |
Active & Upcoming Studies in Athens (2026)
Recruiting trials in Athens grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (23 active studies)
- A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) · Phase 2 · Bristol-Myers Squibb
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · Phase 2 · Pfizer
Diabetes & metabolic (5 active studies)
- Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose · University of Georgia
- Intermittent Cottonseed Oil Consumption · University of Georgia
Mental health & behavior (4 active studies)
- Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services · Beth Israel Deaconess Medical Center
- CLOZAPINE Response in Biotype-1 · Phase 4 · University of Texas Southwestern Medical Center
Neurology & pain (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Athens
- Non-Small Cell Lung Cancer (4 active studies)
- Dyslipidemia (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Nutrition, Healthy (3 active studies)
- Overweight and Obesity (3 active studies)
- Prostate Cancer (3 active studies)
Leading research sponsors in Athens
- University of Georgia
- AstraZeneca
- Novartis Pharmaceuticals
- Pfizer
- 89bio, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Athens?
There are approximately 54 recruiting clinical trials in Athens, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Athens pay participants?
Most recruiting trials in Athens compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Athens?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Athens?
The most common conditions under active study in Athens include Non-Small Cell Lung Cancer (4), Dyslipidemia (3), Non-small Cell Lung Cancer (3), Nutrition, Healthy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Athens?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Athens on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Athens?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Athens?
Recruiting research sites in Athens include University of Georgia, University Cancer & Blood Center, LLC, University Cancer and Blood Center LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Athens right now?
The largest active categories in Athens are Cancer & tumors (23), Diabetes & metabolic (5), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.